Palmroth, M.; Viskari, H.; Seppänen, M.R.J.; Keskitalo, S.; Virtanen, A.; Varjosalo, M.; Silvennoinen, O.; Isomäki, P.
IRF2BP2 Mutation Is Associated with Increased STAT1 and STAT5 Activation in Two Family Members with Inflammatory Conditions and Lymphopenia. Pharmaceuticals 2021, 14, 797.
https://doi.org/10.3390/ph14080797
AMA Style
Palmroth M, Viskari H, Seppänen MRJ, Keskitalo S, Virtanen A, Varjosalo M, Silvennoinen O, Isomäki P.
IRF2BP2 Mutation Is Associated with Increased STAT1 and STAT5 Activation in Two Family Members with Inflammatory Conditions and Lymphopenia. Pharmaceuticals. 2021; 14(8):797.
https://doi.org/10.3390/ph14080797
Chicago/Turabian Style
Palmroth, Maaria, Hanna Viskari, Mikko R. J. Seppänen, Salla Keskitalo, Anniina Virtanen, Markku Varjosalo, Olli Silvennoinen, and Pia Isomäki.
2021. "IRF2BP2 Mutation Is Associated with Increased STAT1 and STAT5 Activation in Two Family Members with Inflammatory Conditions and Lymphopenia" Pharmaceuticals 14, no. 8: 797.
https://doi.org/10.3390/ph14080797
APA Style
Palmroth, M., Viskari, H., Seppänen, M. R. J., Keskitalo, S., Virtanen, A., Varjosalo, M., Silvennoinen, O., & Isomäki, P.
(2021). IRF2BP2 Mutation Is Associated with Increased STAT1 and STAT5 Activation in Two Family Members with Inflammatory Conditions and Lymphopenia. Pharmaceuticals, 14(8), 797.
https://doi.org/10.3390/ph14080797